Midway through trading Tuesday, the Dow traded up 0.06 percent
to 16,706.03 while the NASDAQ dropped 0.28 percent to 4,132.23.
The S&P also rose, gaining 0.03 percent to 1,897.14.
Leading and Lagging Sectors In trading on Tuesday, healthcare
shares were relative leaders, up on the day by about 0.26
percent. Top gainers in the sector included Idera Pharmaceuticals
), Geron (NASDAQ:
), and Idenix Pharmaceuticals (NASDAQ:
). Telecommunications services shares tumbled around 0.37 percent
in Tuesday's trading.
Top decliners in the sector included NQ Mobile (NYSE:
), down 7.2 percent, and Telecom Italia S.p.A. (NYSE:
), off 5.6 percent.
Top Headline On Monday, Elizabeth Arden (NASDAQ:
) reported a wider fiscal-third-quarter loss and announced its
plans to explore its strategic alternatives. Elizabeth Arden
posted a quarterly loss of $26.4 million, or $0.89 per share,
versus a year-ago loss of $1.3 million, or $0.04 per share. Its
adjusted loss came in at $0.84 per share on revenue of $210.8
million. However, analysts were projecting the company to break
even on revenue of $256.9 million. Elizabeth Arden has also hired
Goldman Sachs to explore potential strategic alternatives.
Equities Trading UP Halozyme Therapeutics (NASDAQ:
) shares shot up 15.29 percent to $8.67 after the company
reported a Q1 loss of $0.22 per share and reported that the Data
Monitoring Committee now supported enrollment in its PEGPH20
Shares of Rackspace Hosting (NYSE:
) got a boost, shooting up 9.04 percent to $30.02 after the
first-quarter earnings. Rackspace reported its quarterly earnings
of $0.18 per share on revenue of $421 million.
Keurig Green Mountain (NASDAQ:
) shares were also up, gaining 10.22 percent to $122.02 as Coca
) raised its stake in the company to 16%.
Equities Trading DOWN Shares of DXP Enterprises (NASDAQ:
) were 38.30 percent to $67.20 after the company reported its Q1
earnings of $0.75 per share on revenue of $348.50 million.
Elizabeth Arden (NASDAQ:
) shares tumbled 17.40 percent to $29.43 after the company
reported a wider fiscal-third-quarter loss and announced its
plans to explore its strategic alternatives.
INSYS Therapeutics (NASDAQ:
) was down, falling 6.38 percent to $25.87 on Q1 results. INSYS
Therapeutics reported its adjusted earnings of $0.41 per share on
revenue of $41.60 million. However, analysts were expecting
earnings of $0.28 per share on revenue of $45.63 million.
Commodities In commodity news,
oil traded up 0.65 percent
to $101.24, while gold traded up 0.01 percent to $1,295.90.
Silver traded up 0.06 percent Tuesday to $19.56, while copper
fell 0.49 percent to $3.13.
Eurozone European shares
were mostly higher
The eurozone's STOXX 600 gained 0.19 percent, the Spanish Ibex
Index rose 0.10 percent, while Italy's FTSE MIB Index dropped
Meanwhile, the German DAX jumped 0.55 percent and the French
CAC 40 surged 0.24 percent while UK shares rose 0.21 percent.
Economics The ICSC-Goldman's same-store sales index declined
0.1% in the week ended Saturday versus the prior week.
The NFIB Small Business Optimism Index rose to 95.20 in April,
versus a prior reading of 93.40. However, economists were
expecting a reading of 94.50.
US retail sales increased 0.1% in April, versus a revised 1.5%
rise in March. However, economists were expecting retail sales to
gain 0.4% last month.
The import price index declined 0.4% in April, versus a
revised 0.4% rise in March. However, economists were expecting a
0.3% gain in the index.
The export price index shrank 1.0% in April.
The Johnson Redbook Retail Sales Index gained 1.1% in the
first week of May versus April.
US business inventories rose 0.40% in March, versus
economists' expectations for a 0.40% gain.
© 2014 Benzinga.com. Benzinga does not provide investment
advice. All rights reserved.
Free Trading Education -
Check out the free events taking place on Marketfy
this week. Spaces are limited. Sign up today.